Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

ESMO Asia mCRC Guidelines: Insights on Impact and Uptake

October 12th 2018

Dr. McCollum on Maintenance Therapy for Metastatic CRC

October 10th 2018

A. David McCollum, MD, oncologist, Baylor University Medical Center, discusses maintenance therapy for patients with metastatic colorectal cancer.

Dr. Singal on the Potential for Immunotherapy in HCC

October 9th 2018

Amit G. Singal, MD, associate professor, UT Southwestern Medical Center, discusses the potential of immunotherapy in the treatment landscape of hepatocellular carcinoma.

Dr. Becerra Discusses Dosing Strategies in CRC

October 5th 2018

Carlos Becerra, MD, medical oncologist, Texas Oncology, discusses dosing strategies in the treatment of patients with colorectal cancer.

Oncolytic Virus Explored in Advanced HCC

October 5th 2018

Ghassan K. Abou-Alfa, MD, discusses the potential of the oncolytic virus Pexa-Vec and other developments in hepatocellular carcinoma.

Fuchs Illuminates Associations Between Cancer, Lifestyle Habits

October 4th 2018

Charles S. Fuchs, MD, MPH, has investigated associations between lifestyle choices of food and exercise and cancer diagnosis and survivorship, leading to important insights that have clarified the relative value of diets that include nuts, alcohol, and legumes, among other foods.

Dr. Pinato on PD-L1 Testing in HCC

October 2nd 2018

David J. Pinato, MD, NIHR Academic Clinical Lecturer in Medical Oncology, resident, Royal Brompton Hospital and Imperial College London, discusses the role of PD-L1 testing in hepatocellular carcinoma.

Dr. Cheng on the Need For Biomarkers in HCC

September 28th 2018

Ann-Lii Cheng, MD, distinguished professor, Department of Internal Medicine, National Taiwan University College of Medicine Director, Graduate Institute of Oncology, director, Department of Medical Oncology, discusses the need for biomarkers in hepatocellular carcinoma.

Later Lines of Therapy for Metastatic Colorectal Cancer

September 28th 2018

Future Management of Metastatic Colorectal Cancer

September 28th 2018

Emerging Therapy in Metastatic Colorectal Cancer

September 28th 2018

BEACON Trial: Triplet Therapy in BRAF V600E

September 28th 2018

Other I-O Approaches to Metastatic Colorectal Cancer

September 28th 2018

I-O Therapy in mCRC: Ipilimumab + Nivolumab

September 28th 2018

ReDOS Trial: Optimizing Regorafenib Dosing in metastatic Colorectal Cancer

September 28th 2018

Metastatic Colorectal Cancer: Multiple Lines of Therapy

September 28th 2018

Next-Generation Sequencing and Molecular Subsets in Metastatic Colorectal Cancer

September 28th 2018

The Current Paradigm of Metastatic Colorectal Cancer

September 28th 2018

Dr. Basu on Second-Line Therapy in HCC

September 28th 2018

Bristi Basu, MD, honorary consultant medical oncologist, University of Cambridge, discussed second-line therapy for patients with hepatocellular carcinoma.

Dr. Paulson Discusses Unmet Needs in the Treatment of NETs

September 27th 2018

Scott Paulson, MD, co-director of the Gastrointestinal Research Program for The US Oncology Network, medical director for the Neuroendocrine Research and Treatment Center at Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, discusses unmet needs in the treatment of patients with neuroendocrine tumors.